Tuesday, 3rd July First Malaria World Congress 2018

• Malaria in the broader context of Universal Health Coverage and the Sustainable Development Goals - Barbara McPake
• Malaria in the context of Universal Health Coverage - Hideo Suzuki

Panel "The Role of Global and Regional Partnerships"
Facilitator: Dr Winnie Mpanju-Shumbusho, Board Chair, RBM Partnership to End Malaria

• Lelio Marmora, Unitaid
• Ruby Shang, Asia Pacific Leaders Malaria Alliance
• Bob Aitken, Rotary International District 9685 Inc
• Dianne Stewart, The Global Fund to Fight AIDS, Tuberculosis and Malaria
• Sherwin Charles, Goodbye Malaria

• Starting with the end in mind – designing and delivering the anti-malarial medicines of tomorrow - David Reddy
• The Importance of PK to Meet Current Target Candidate Profiles - Susan Charman
• Accelerating clinical development of antimalarials - James McCarthy
• To be provided - BT Slingsby
• Business Case for engagement in malaria elimination for Newcrest Mining Limited - Graeme Hancock

Panel Discussion: "Engagement & Role of the Private Sector"
Facilitator: Dr BT Slingsby, Global Health Innovative Technology Fund

• Jayeeta Chowdhury, Tata Trusts
• Ray Nishimoto, Sumitomo Chemical Co.,Ltd.
• Dr Graeme Hancock, Newcrest Mining Limited
• Dr Wit Soontaranun, DT Families Foundation

• Introduction to METF - Francois Nosten
• ACT Resistance on the Thai-Myanmar Border (AAF nominee) - Aung Pyae Phyo
• Strategy of METF and impact - Jordi Landier
• Trends in Molecular markers and resistance - Aung Myint Thu
• Community engagement in malaria elimination - Ladda Kajeechiwa
• Importance of monitoring and evaluation - Jade Rae
• Entomological determinants of malaria elimination - Victor Chaumeau
• Malaria Elimination Task Force in silico - Lisa White
• Governance, politics and conclusion - Arjen M. Dondorp

Followed by Panel Discussion and Q&A

The Congress would like to acknowledge that the follow speaker is an Australia Awards Health Security Fellow:

• Aung Pyae Phyo
• Aung Myint Thu

• Mosquito population modification and the malaria eradication agenda - Anthony James
• Genetic surveillance of drug-resistant malaria to support elimination in the Greater Mekong Subregion - Olivo Miotto
• Entomological surveillance as a cornerstone of malaria elimination: a critical appraisal - Gerry F Killeen
• Fine-scale spatial and temporal heterogeneities in insecticide resistance profiles of Anopheles arabiensis in rural south-eastern Tanzania - Nancy NSM Matowo
• Malaria vector surveillance - can vector data guide global policy and programmatic vector control decision-making? - Thomas Burkot
• Global vector control response: a strategic approach to tackle vector-borne diseases - Kim Lindlabde
• Lessons learnt from integrated control - drug-based methods - Louise Kelly-Hope
• Saving lives through innovation in vector control collaborative efforts leading to novel solutions in vector control. - Nick Hamon
• To be provided - Khin Nan Lon

Presentations followed by Q&A 

• CSS overview and how it is critical to effective malaria responses - Khuat Thi Hai Oanh
• Financing CSS: Case of Global Fund funding of Malaria CS Platform work under RAI2E - Shreehari Acharya
• Importance of, and challenges around sustaining and scaling up work of village health workers - Maurice Odindo
• Malaria Matchbox as a tool for ensuring community, rights and gender programming in malaria responses - Kate Thomson

Panel Discussion: “Country experiences - CSS approaches and interventions in the context of malaria and sustaining the responses”
Facilitator: Dr Oanh Khuat Thi Hai, Center for Supporting Community Development Initiatives

• Shampa Nag, Caritas India
• Willy Mwanafunzi, Faith Victory Association
• Yohanes Hermawan, PERDHAKI, Indonesia (Programme Manger of Principle Recipients)
• Scott Filler, The Global Fund to Fight AIDS, Tuberculosis and Malaria

 Mr Lelio Marmora, Executive Director of Unitaid and Dr Ben Rolfe, Chief Executive Office of the Asia Pacific Leaders Malaria Alliance announce a new Platform for Vector Control in Asia Pacific – VCAP.

We need new tools now to stop malaria transmission and eliminate by 2030 in the Asia Pacific.

VCAP is designed to address policy challenges to vector control in the region by both promoting innovation and improving access to new tools to stop transmission of malaria and other vector borne diseases. VCAP will facilitate the adoption of technical solutions by creating an enabling policy environment and relaying technical challenges to decision makers.

The objectives

1. To stimulate innovation by generating demand for new tools that respond to the key challenges of the region including insecticide resistance and specific behaviour patterns of populations at risk
2. To improve access to market for new innovations, e.g. by identifying opportunities for facilitated country registration

The partners

VCAP will link regulators, policy makers, industry, academia and the global health community to find solutions to policy barriers to innovation and access for new vector control tools, so that we can stop malaria transmission and by doing so, improve health security against other vector borne diseases.

The approach

VCAP will serve as a knowledge management platform for partners working on vector control tools in the region. This will include the creation of a network of regulators with key contact points on access to vector control tools in Asia Pacific. Two-way information exchange will be facilitated through web-based tools (e.g. listserv, webinars) as well as through targeted side meetings at existing key events in the region.

12:45 Opening remarks on the Platform: Mr Lelio Marmora, Executive Director, Unitaid and Dr Ben Rolfe, Chief Executive Officer, APLMA

12:55 Introduction to VCAP Platform: Dr Alexandra Cameron, Technical Manager, Unitaid
Enabling a supportive policy environment for new vector control tools in Asia Pacific: policy dialogue and launch of a new regional platform

13:05 Objective 1. Innovation

• New tools for Asia Pacific: Mr Ray Nishimoto, Representative Director & Senior Managing Executive Officer, Sumitomo Chemical
• Challenges and opportunities for R&D: Dr Nick Hamon, CEO of IVCC

13:15 Objective 2. Access

• Barriers to access: TBC
• Opportunities to address these barriers: TBC

13:25 Concluding remarks

13:30 Photo

Sponsored by APLMA & UNITAID

• To be provided - Stephanie Williams
• Regional, national and subnational health systems investments for malaria elimination- Experiences and lessons learned - Susann Roth
• To be provided - George Okello
• Is a push for malaria eradication compatible with broader health and development goals? - Jim Tulloch
• To be provided - Khuat Thi Hai Oanh

Followed by Q&A Panel Discussion

2:10 pm: Panel Discussion "Meeting migrant and mobile peoples needs and wants: Lessons from the Greater Mekong Region"

• Overview of mobility and universal health access - what do we know - Shreehari Acharya
• Reaching tribal populations in India - Avdhesh Kumar
• Migrant health volunteers engagement in malaria elimination in Thailand - Sai Ti
• One size does not fit all: a tailored approach to diverse plantation worker preferences - Lorina McAdam
• Mobile malaria services reaching border crossers, ethnic communities and forest goers in North East Cambodia - Kylie Mannion
• Prevention of malaria in pregnancy among pastoralists in a humanitarian setting: An exploratory study of ambulatory service delivery models for administering prophylaxis - Emmanuel Victor EVO Odjidja
• Understanding malaria treatment-seeking preferences within the public sector amongst mobile/migrant workers in a malaria elimination scenario: a mixed-methods study - Aung Ye Naung Win
• The social co-relation between malaria, water, sanitation and hygiene among internally displaced people {IDPs} and illegal migrant health: an epidemiological review of social implication of migration and population health in Sub-Sahara Africa - Benjamin B Bob

Followed by Q&A Discussion

• Background and rationale for triple artemisinin combination therapies in falciparum malaria - Arjen M. Dondorp
• Results of a large clinical trial evaluating triple ACTs in Asia and Africa (TRAC II) - Rob van der Pluijm
• Targetting the malaria parasite proteasome for drug development - Leann Tilley
• The intersection of Australia's Leadership in Malaria Elimination and Health Security - Robin Davies
• Financing core health systems for essential services and security: integrating the agendas - Aparnaa Somanathan
• Drug resistant malaria and fake antimalarials: a regional and global health security threat - Marie CM Lamy

• Stengthening capacity for quality malaria diagnosis in PNG - Evelyn Lavu
• Provision of technical expertise in malaria diagnostics and control - Zhou Xiao-Nong
• Trilateral Malaria Project Operational Research: An Update - William Pomat

Panel Discussion: "Building effective partnerships for collaborative action against malaria"
Facilitator: Sarah MacCana, Australia-China-Papua New Guinea Pilot Cooperation on Malaria Control Project

• Leo Makita, National Department of Health, Papua New Guinea
• Dr Moses Laman, Papua New Guinea Institute of Medical Research
• Dr Junhu Chen, National Institute of Parasitic Diseases
• Dr Leanne Robinson, Burnet Institute
• Will Robinson, Australian High Commission to Papua New Guinea

• The Role of Surveillance, Mapping, and Targeting Interventions in Malaria Elimination and Burden Reduction - Philip Welkhoff
• Antimalarials & drug resistance - Arjen M. Dondorp
• Vector control in the context of elimination & eradication - Janet Hemingway

Panel Discussion "Malaria in a global health context"
Facilitated by Prof Kevin Marsh

• Dr Philip Welkhoff, Bill & Melinda Gates Foundation
• Prof Barbara McPake, The University of Melbourne
• Dr Susann Roth, Asia Development Bank
• Shreehari Acharya, American Refugee Committee
• Ray Nishimoto, Sumitomo Chemical

• Malaria microscopy quality assurance quality control program:Zanzibar experience. - Safia Mohammed Ali
• Safety of primaquine as an antirelapse agent: Data from India - Anupkumar R Anvikar
• Malaria in children  - Drusila Atassem
• Are we ready for malaria elimination? Evaluation on health staff in pre-elimination settings in Myanmar - Poe Poe Aung
• Identifying positive selection in P. falciparum using identity by descent - Melanie Bahlo
• Flow-cytometric analysis of intracellular G6PD activity for vivax malaria studies - Germana Bancone
• A high throughput screen for next-generation leads targeting malaria parasite transmission - Jake Baum
• Population genetic evaluation of the Southwest Pacific malaria vector Anopheles koliensis (Owen) suggests the existence of two species in New Guinea with landscape topology mostly driving population structure - Nigel W Beebe
• A research methodology on the role of community health workers and volunteers in scaling integrated delivery of community case management implementation for the elimination of malaria in Sub-Sahara Africa  (A field experience and strategic approach for strengthening low-cost effective evidence-base interventions in an epidemic control program of Fhi360/USAID/SIDHAS/PEPFAR project in Southern Nigeria) - Benjamin B Bob
• Declining malaria transmission impacts immunity to severe malaria - Philippe Boeuf
• Development of a WHO international standard for the quality control and harmonization of Plasmodium falciparum antigen detection assays - Paul W Bowyer
• Towards a predictive model of human malaria infection treatment and transmission control - Pengxing Cao
• Assessing the impact of imperfect adherence to artemether-lumefantrine on onward transmission of the Plasmodium falciparum parasite using within-host modelling - Joseph D Challenger
• T-follicular helper cells in the induction of functional antibodies in children in high malaria transmission areas - Jo-Anne Chan
• Identification and characterization of PvRBP2b-specific monoclonal antibodies from mouse memory B cells by single cell cloning - Yijun Chen
• Identification of gene regulatory elements in the malaria parasite Plasmodium falciparum - Scott Chisholm
• A systems biology approach to characterizing Plasmodium falciparum responses to high parasite density - Evelyn S Chou
• Comparison of the cumulative efficacy and safety of chloroquine, artesunate and chloroquine-primaquine in Plasmodium vivax malaria - Cindy S Chu
• Differential plasma microvesicle and brain profiles of microRNA in experimental cerebral malaria - Amy Cohen
• The risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis - Robert J Commons
• Increase in incidence of Plasmodium knowlesi malaria in Sabah, Malaysia, including fatal cases, despite near-elimination of the human-only Plasmodium species - Daniel J Cooper
• Outbreak of human malaria caused by Plasmodium simium in the Atlantic Forest of Rio de Janeiro - Richard Culleton
• Associations between red blood cell polymorphisms and maternal and birth outcomes in a malaria endemic region of Papua New Guinea: a cohort study - Eliza M Davidson
• Development and evaluation of a Plasmodium vivax specific loop-mediated isothermal amplification diagnostic kit  - Xavier C Ding
• A triage test to guide the management of malaria negative infections: what are potential biomarkers to support decision making? - Sabine Dittrich
• Susciter un engagement national soutenu, à la fois politique et financier, pour l'élimination du paludisme - Maelle Ba
• Infectious cycle knowledge, key to prevention and treatment of malaria in rural communities in Nigeria - John Ede
• T Cell response to an MHC-II-restricted epitope of rodent malaria. - Matthias Enders
• Malaria child mortality in South America 2000-2015 - Virgilio E Failoc Rojas
• Opsonic phagocytosis of sporozoites is an important mechanism in immunity against Plasmodium falciparum - Gaoqian Feng
• Effectiveness of repellent delivered through village health volunteers on malaria incidence in villages in South-East Myanmar: a stepped-wedge cluster-randomised controlled trial - Freya JI Fowkes
• Leveraging lessons learned from malaria service delivery programs to expand integrated community case management in remote areas of Papua New Guinea - Carrie Madison Gheen
• Revealing the biochemical pathways targeted by peroxide antimalarials in 3D7 and K13-mutant artemisinin-resistant Plasmodium falciparum with metabolomics and proteomics - Carlo Giannangelo
• Plasmodium falciparum artemisinin in vivo efficacy monitoring and molecular drug-resistance surveillance in a pre-elimination setting in Sabah, Malaysia. - Matthew J Grigg
• BioStructMap: A Python tool for integration of protein structure and sequence-based features - Andrew Guy
• Static and temporal signatures of immune selection in Plasmodium falciparum revealed through network analyses of var genes and their repertoires - Qixin He
• Challenges in the treatment of acute falciparum malaria in Viet Nam - Nghia Ho Dang Trung
• Perception and utilization of preventive measures of malaria among tribal adults in higher endemic community  - Aktaruzzaman MM
• Identifying Plasmodium vivax encoded proteins that prevent host cell death during liver development - June Hu
• Characteristics of epidemiology of childhood malaria in association with ecology in a hyperendemic area  - Zahirul Islam
• Adaptations to Plasmodium falciparum and P. vivax malaria: The case of ethnic minority children in the chittagong hill tracts, Bangladesh - Zahirul Islam
• Development of a highly sensitive multiplex ELISA for detection of subclinical Plasmodium falciparum and Plasmodium vivax infection - Ihn Kyung Jang
• Repurposing cancer drugs - a new perspective for antimalarial drug discovery? - Simona John von Freyend
• Suppression of B cell immune responses by low doses of chloroquine and pyrimethamine; implications for studying B cell immunity in malaria - Hayley Joseph
• Quantification of chloroquine and its metabolite in different biological matrices by liquid chromatography tandem mass spectrometry (LC-MS/MS) - Karnrawee Kaewkhao
• Refined sub-structure of Plasmodium falciparum (Pf) populations in sub-Saharan Africa and the implications for the emergence and spread of artemisinin resistance  - Edwin Kamau
• Experiences of 2016 Mass LLINs distribution Zanzibar - Mwinyi Issa Khamis
• Platelets kill all major Plasmodium species in human malaria - Steven Kho
• Intensified malaria control project in north-eastern states: a success story of malaria control in India - Avdhesh Kumar
• Malaria prevention: development of implantable malaria chemoprophylaxis  - Jangwoo Lee
• Characterisation of PfATP4-associated Na⁺-ATPase activity in Plasmodium falciparum membranes - Adele M Lehane
• Low risk of recurrence following artesunate-sulfadoxine-pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan - Kamala Thriemer
• Are village health volunteers as good as basic health staffs in providing malaria care? A country wide analysis from Myanmar, 2015 - Nay Yi Yi Linn
• Activation of non-classical dendritic cells in controlled human malaria infection studies with Plasmodium falciparum - Jessica R Loughland
• Inflammation mediated by T-bet during blood-stage infection modulates the development of humoral immunity to malaria - Ann Ly
• Chloroquine uptake and efflux studies in clinical Plasmodium falciparum and P. vivax field isolates reveal important differences between species - Jutta Marfurt
• What roles do PfCRT and PfMDR1 play in the malaria parasite’s acquisition of amodiaquine resistance? - Jamie D Robertson
• Characterisation of the malaria parasite’s ‘multidrug resistance protein 1' in Xenopus laevis oocytes   - Sashika N Richards
• Wearing practices, durability, and insecticidal effect of insecticide-treated clothing in a migrant rubber plantation community, Myanmar - Thae Maung Maung
• The Anopheles farauti habitat and its association with larval density and adult fitness - Kimberley McLaughlin
• Structure function analyses of the interactions between a Plasmodium vivax adhesin and the essential housekeeping protein Transferrin Receptor - Sebastien Menant
• Aging-dependent activation of CD25⁺Foxp3⁺CD127^lo CD4 regulatory T cells in Plasmodium knowlesi malaria - Gabriela Minigo
• Integrating with immunization for malaria control: demand-side evidence from Papua New Guinea linked to a global systematic review of integrated service delivery - Christopher Morgan
• Prevalence of malaria, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women - Ritah F Mutagonda
• Investigating host proteins that define Reticulocyte maturation and its contribution to plasmodium infection - Renugah Naidu
• Re-expansion of chloroquine sensitive haplotypes in the P. falciparum reservoir of infection in Bongo District, Ghana. - Charles A Narh
• Characterisation of bromodomain protein in the malaria parasite Plasmodium falciparum - Hanh Nguyen
• Safety and feasibility of using apheresis to harvest Plasmodium vivax parasites from experimentally infected subjects - Anand A Odedra
• “Every day they keep adding new tools but they don’t take any away”: Producing indicators for intermittent preventive treatment for malaria in pregnancy (IPTp) from routine data in Kenya - George Okello
• Antibody-complement interactions in immunity to malaria in pregnancy - Daniel Herbert Opi
• The impact of age on the induction of complement-fixing antibodies to P. vivax MSP3α in Sabah, Malaysia - Damian Oyong
• Early and late mortality after falciparum and vivax malaria in children under five years old in Papua, Indonesia - Jeanne Rini Poespoprodjo
• Longitudinal characterization of P. vivax and P. falciparum genetic diversity and structure in Papua, Indonesia between 2004 and 2016 - Agatha M Puspitasari
• Unravelling the roles of multiple processes behind Plasmodium vivax malaria mitochondrial genome diversity - Leonie Raijmakers
• Development of an artemisinin-resistant induced blood stage malaria model - Maria Rebelo
• Infrared spectroscopy for point-of-care diagnosis of asymptomatic malaria – a field trial in remote villages in Laos - Anja Ruether
• The role of extracellular vesicles in the modulation of endothelial junctions in an in vitro model of cerebral malaria - Benjamin C Sealy
• High malaria endemic districts report a dramatic reduction in new malaria cases in Madhya Pradesh, India - Som Sharma
• From phenotypic screens to mode of action: guiding the development of novel antimalarial drugs - Anubhav Srivastava
• The pattern of malaria transmission in the coastal ecosystem (case study Nongsa Batam Village, Batam City, Kepulauan Riau Province)  - Dewi Susanna
• Treatment of drug resistant malaria cases with a herbo mineral drug in india - Prakash Tahiliani
• The 4^th option of minimizing malaria’s infection rate  - Dessalegn Temesgen Leye
• A study to evaluate the safety and immunogenicity of the malaria vaccine candidate BK-SE36 in young children naturally exposed to malaria transmission in Burkina Faso - Alfred Bewendtaore Tiono
• A bioreactor system for the manufacture of genetically modified Plasmodium falciparum blood stage malaria cell banks for in vivo clinical trials - Katharine Trenholme
• Evaluation of an Ultra-sensitive rapid diagnostic test for the detection of asymptomatic malaria during pregnancy - Vera T Unwin
• Increasing Plasmodium immunogenicity during liver stage infection to induce protective CD8⁺ T cell immunity against malaria - Ana Maria Valencia Hernandez
• The complex role of programmed death-1 (PD-1) in preventing malarial immunity  - Michelle Wykes
• Investigating simplified intravenous artesunate dosing regimens for the treatment of sensitive and resistant severe malaria infections - Sophie Zaloumis
• Health communications management personal orientation situational factors and treatment seeking behaviour regarding malaria in Uganda - Frank Dr Ahimbisibwe
• Neutrophil Antibody dependent respiratory burst towards the infected erythrocyte protects against Placental Malaria - Elizabeth Aitken
• Development of small molecule inhibitors of the AMA1/RON2 interaction using a paramagnetic peptide probe - Mansura Akter
• An operational review of the rollout of case investigation in the Ayeyarwady Region of Myanmar - Moe Moe Aye
• Untargeted metabolomics identifies novel mechanism of action and putative targets of new antimalarial drugs in development JPC-3210 and TSC-3 - Geoff W Birrell
• A case of blackwater fever with persistent Plasmodium falciparum parasitaemia detected by PCR after arthemeter-lumefantrine treatment - jean-marc chavatte
• Global Fund's investment towards malaria elimination in Vanuatu - Anna Ms Chernyshova
• Calculating U5 and maternal lives saved from mass LLIN distribution and effective treatment using the lives saved tool - Alexander Chikonga
• A systematic review of pregnancy-specific P. falciparum antibody responses and placental and birth outcomes - Julia C Cutts
• Liposome conjugation potentiates the immune response towards conserved epitopes of the malaria vaccine candidate MSP2 - Sreedam C. Das
• Thailand leverages geo-referenced malaria information to increase local ownership and funding for malaria elimination - Prayuth Sudathip
• Locating and characterising M1 and M17 aminopeptidases in Plasmodium falciparum - Rebecca Edgar
• Enhanced functional activity and long-term transcriptional changes in memory γδ T cells following malaria infection. - Emily M Eriksson
• Pathways to cure: care-seeking behavior and antimalarial drug use in Eastern Indonesia - Supargiyono Supargiyono
• Characterization of Plasmepsin X as a Cross-species Antimalarial Target - Kaiyuan Guo
• Comparison of ultra-sensitive real-time PCR versus Multiplex Enzyme-linked Immunosorbent assay to detect asymptomatic Plasmodium infections in Eastern Myanmar - Jordi Landier
• Profiling the effect of anti-plasmodial HDAC inhibitors on histone acetylation - Eva Hesping
• Spatial organisation of protein export in Plasmodium falciparum - Thorey Jonsdottir
• High-performance and fully automated hematology analyzer XN-30 useful for malaria detection - Mina Kamei
• Evaluation of Automated Hematology Analyzer XN-30 using blood samples of clinical malaria patient - Shigeyuki Kano
• 0010 View over Shin Hkaung Village Tract, Khaunglanhpu Township: This S-shaped road leads to Shin Hkaung. The only asphalt road in Kachin Special Region 1 is in Pangwa town centre, and it is only 100m long. 0020  In front of the church in Tsawlaw Township: A villager is communicating by walkie talkie because there is no landline or mobile network. The range of a walkie talkie is about 10 km. Messages must be passed on several times if they need to be sent more than 10km.  1005 Dr. Zhang Jun (Regional Director of HPA’s East Asia Program Office): Balancing on a tree trunk to cross a cliff during a monitoring visit with an HPA field team. 1007,1008   Li Bixian and Khao Ze (HPA malaria field workers):  Crossing a rattan bridge, which is only wide enough for one person, during a supervision trip to visit Village Malaria Volunteers. Many project villages in this area cannot be accessed by road, and it can take a 1-2 day’s walk to reach them. 1029 Shin Hkaung Village Tract, Khaunglanhpu Township: A member of HPA’s outreach team is pricking a boy’s finger to get blood for a rapid malaria test. 1030 Shin Hkaung Village Tract, Khaunglanhpu Township: The outreach service is conducted in the local priest’s house. 1070  Khao Ze (HPA Community Mobiliser): Khao Ze loves music and uses songs to communicate malaria information. He has added malaria prevention messages to a hymn that is sung in the local church and is teaching the song to the church choir. 2004 Yong Tsawi, a 25-year old Village Malaria Volunteer in Kyan Htan Village, Phimaw Township: Yong Tsawi is also a teacher in the local church. She is in front of her dormitory carrying malaria registers and stationaries n her baskets. 2008 Chaung Nyoi, 26-year-old Village Malaria Volunteer, from the village of Gaw Mau: Each November, when the weather is better and the May Hka River is calm, Chaung Nyoi crosses the river on a bamboo raft and walks across the forest for 2 hours to submit the malaria registers for her village to HPA. 1041,1042  Chong Noi crossing May Hka River in a bamboo raft. 2013 Li Bixian (Deputy Manager of HPA’s Pangwa Office) and Khao Ze (Community Mobiliser): Taking a rest on the way to a program site. Li Bixian was the first woman to work in HPA’s Pangwa Office (“And the only one for a long time.”, she says). Most villages in their program area can only be reached on foot, so they spend the entire day walking. This is Li’s seventh year with HPA. 2014 Tian Yanghui (Manager of HPA’s Pangwa Office): Talking to an officer at a border guard check point. Tian Yanghui has worked for HPA in Kachin Special Region 1 for seven years. Since the establishment of the Pangwa Office, they have experienced armed conflict, a changing governance system and unstable situation, but they have never stopped their work. 2015 Dr. Zhang Jun (Regional Director of HPA’s East Asia Program Office): Having lunch during a monitoring visit to May Hka River with a field team.   The border area between Khaunglanhpu Township and China: This mountainous area is at an altitude of over 3,000m. The only route to access the area is covered by heavy snow from December to May. When there is no snow, it takes a day to climb over the mountain and another 10 days on foot to reach the nearest township, Puta-O. - Xianxian Lin
• Guiding malaria surveillance system transitioning through effective monitoring and evaluation: Lao PDR's rollout of DHIS2 for passive case detection - Saosavanh Saosavanh
• Using serological and geospatial markers to improve malaria surveillance in varying endemic settings in the Philippines - Maria Lourdes Macalinao
• Use of mobile technology-based participatory mapping approaches to geolocate health facility attendees for disease surveillance in low resource settings - Ralph Reyes
• Characterisation of gametocyte-specific antibodies in sera from malaria-infected individuals to identify the functional determinants of transmission blocking immunity - David Grimson
• Mechanisms for PfCRT-induced hypersensitivity to quinoline dimers in the malaria parasite - Simone Babij
• Neutrophil extracellular traps (NETs) play a role in the control of Plasmodium falciparum malaria - Agersew Alemu AM Mengist
• A survey on asymptomatic malaria by make a use of microscopy in Helmand province, Afghanistan - Moqadas Mosavi
• Pilot Mapping And Real Time Reporting And Responding In High Risk Malaria Areas Of Viet Nam - Xuan Thang Nguyen
• Arthropod venoms: a new source of natural products for antimalarial drug discovery - Samantha Nixon
• Research towards malaria diagnostic and vaccine development in Indonesia - Rintis Noviyanti
• Southeast Asian Ovalocytosis Profile in Malaria Endemic Area in Southwest Sumba - Lydia V Panggalo
• Investigating human to mosquito transmission of artemisinin-resistant parasites in the induced blood stage malaria model  - Zuleima Pava
• Vesicular BioID reveals transmission-blocking vaccine candidates - Emma Pietsch
• Evaluating the Public Health Impact of 3rd Generation IRS Products - Molly Robertson
• Identification of the molecular arrangement of EXP2, an essential component of the PTEX protein export machine within the malarial parasitopherous vacuole membrane reveals a pore-forming domain. - Paul R Sanders
• A participatory approach to addressing within-country cross-border Malaria: the case of Menoreh Hills, Indonesia - Henry S Saridah
• Decreasing susceptibility of chloroquine in Korean vivax malaria - Hye Seong
• Investigations on novel compounds with high disruptive potency against the digestive vacuole of plasmodium falciparum - Jie Xin Tong
• Antibody responses to Plasmodium falciparum merozoite antigens and sequence polymorphisms of invasion ligands in symptomatic individuals from Timika district, Papua, Indonesia - Leily LT Trianty
• Absence of Resistance-Associated Mutations in pfcrt and k13 genes of Plasmodium falciparum Isolates from Haiti - JEANNE PERPETUE VINCENT
• A public private partnership reduces malaria in Timika Papua - Govert Mr Waramori
• A one-stop pH-based screen to identify inhibitors of H⁺ transporters on the P. falciparum plasma membrane - Xinxin Zhang

Interactive session between civil society, government, development partners scientists and other interested parties on Role of community engagement in effective Surveillance to eliminate malaria Facilitated by Mr Louis de Gama and Mr Shree Acharya Malaria CSO Platform, Greater Mekong Region

In 2014, 18 Heads of Government committed, for the first time, to an Asia Pacific free of malaria by 2030. This has generated a concerted effort by partners; but are these efforts enough? 

The World Malaria Congress presents an opportunity to have a candid discussion about what it will take to end malaria for good in Asia and the Pacific. 

APLMA and APMEN will jointly host a “dialogue” between Congress delegates and representatives from the APLMA Board of Directors, APLMA Secretariat, APMEN Secretariat and other global and regional stakeholders and partners. Delegates are invited to pose questions and engage in a discourse on how partnerships can accelerate progress to the 2030 goal.

Light refreshments will be served. 

• GIVeS: A collaborative effort for GIS capacity building in vector surveillance - Michael Coleman
• A new simple test for the detection of insecticide resistance markers in mosquitoes. - Vera T Unwin
• The impact of within-vector dynamics on malaria parasite diversity - Lauren M Childs
• The threat of insecticide resistance for malaria control and elimination - Melinda P Hadi
• New vector control technologies    Attractive targeted sugar bait   - Mathias Mondy

• Transporters as determinants of drug resistance in the malaria parasite. - Rowena E Martin
• Multi-omics analysis of artemisinin resistant Plasmodium falciparum malaria parasites demonstrates key roles of glutathione and haemoglobin metabolism - Ghizal Siddiqui
• Elucidation of a novel nuclear mechanism of action for potent bis-triazine antimalarials - Darren Creek
• Integrated pathogen load and dual transcriptome analysis of systemic host-pathogen interactions in severe malaria - Hyun Jae Lee
• Delayed death in the malaria parasite: disruption of prenylation-dependant intracellular trafficking - Kit Kennedy

• Intermittent preventive treatment (IPT) or intermittent screening and treatment (IST) with dihydroartemisinin-piperaquine for the control of malaria in pregnancy (MiP) in Indonesia: an open label cluster-randomized controlled trial - Rukhsana Ahmed
• Surveillance of malaria in pregnancy and monitoring the effectiveness of malaria elimination - Verena I Carrara
• Bringing innovation to malaria in pregnancy through community engagement in Sub Saharan Africa - Katerina Galluzzo
• Progress on malaria in pregnancy in PMI focus countries - Katherine Wolf
• Influence of antenatal malaria screening in an area of low transmission on birthweight-for-gestational age - Julie A Simpson
• Submicroscopic qPCR Plasmodium falciparum and P.vivax infection at the first antenatal visit: maternal and neonatal outcomes - Rose McGready